Interferon alpha-2a monotherapy for necrobiotic xanthogranuloma.
Georgiou
S
S
Monastirli
A
A
Kapranos
N
N
Pasmatzi
E
E
Sakkis
T h
Th
Tsambaos
D
D
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001707:Biopsy, Needle; D005500:Follow-Up Studies; D006099:Granuloma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D008297:Male; D011994:Recombinant Proteins; D012871:Skin Diseases / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome; D014973:Xanthomatosis / Q000188:drug therapy* / Q000473:pathology
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins